Skip to content
Recall Observatory FDA recall evidence

Drug product

Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp. Weston, FL 33326, NDC 60505-1005-4

D-0093-2023

December 21, 2022

Class III

Product summary

Firm
Apotex Corp.
Event
Event 91353
Status
Terminated
Classification
Class III
Quantity
22,027 bottles
Official record key
drug-enforcement:D-0093-2023

Official wording

Reason: Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.

Code information: Lot# TA4844, Exp 03/2023

Distribution pattern: USA Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification